Immunoglobulin G has a role for systemic protein modulation in vivo: A new concept of protein homeostasis

Medical Hypotheses

Volumn 67, Issue 4, 2006, Pages 848-855

  Lee, Kyung Yil ^a   Lee, Joon Sung ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G;

ALBUMIN BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; CORRELATION ANALYSIS; DOSE RESPONSE; GLOMERULONEPHRITIS; HOMEOSTASIS; HUMAN; HYPERPHOSPHATASEMIA; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; KIKUCHI DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEPHROTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SENSITIVITY ANALYSIS;

ANIMALS; HOMEOSTASIS; HUMANS; IMMUNOGLOBULIN G; MODELS, IMMUNOLOGICAL; PROTEINS;

CANIS FAMILIARIS;

EID: 33745932908     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.011     Document Type: Article

References (57)

1. Dwyer J.M. Manipulating the immune system with immune globulin. N Engl J Med 326 (1992) 107-116
2. Kazatchkine M.D., and Kaveri S.V. Immune modulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345 (2001) 747-755
3. Sapir T., and Shoenfeld Y. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin. Clin Rev Allergy Immunol 29 (2005) 185-199
4. Lee K.Y., Han J.W., Lee J.S., and Whang K.T. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Paediatr 91 (2002) 64-67
5. Lee K.Y., Lee H.S., Hong J.H., Han J.W., Lee J.S., and Whang K.T. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki disease. J Trop Pediatr 51 (2005) 98-101
6. Song YH, Lee KY, Kim DU, Koh DK, Lee BC. Correlation of serum IgG level with albumin level in minimal change nephrotic syndrome. Program and Abstract, the 54th Annual Fall Meeting of the Korean Pediatric Society, October 22-24, 2004, Seoul. Seoul: The Korean Pediatric Society; 2004. p. 454.
7. Kim HJ, Lee KY, Kim DU, Koh DK, Lee BC. The level of immunoglobulins in acute poststreptococcal glomerulonephritis. Program and Abstract, the 54th Annual Fall Meeting of the Korean Pediatric Society, October 22-24, 2004, Seoul. Seoul: The Korean Pediatric Society; 2004. p. 454.
8. Lee K.Y., Yeon Y.H., and Lee B.C. Kikuchi-Fujimoto disease with prolonged fever in children. Pediatrics 114 (2004) e752-e756
9. Nicholson J.F., and Pesce M.A. Reference ranges for laboratory tests and procedures. In: Behrman R.E., Kliegman R.M., and Jenson H.B. (Eds). Nelson textbook of pediatrics. 17th ed. (2004), International edition, Saunders 2408
10. Mok C.C., and Lau C.S. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56 (2003) 481-490
11. Potter E.V., Shaughnessy M.A., Poon-King T., and Earle D.P. Serum immunoglobulin A and antibody to M-associated protein in patients with acute glomerulonephritis or rheumatic fever. Infect Immun 37 (1982) 227-234
12. Rodriguez-Iturbe B., Carr R.I., Garcia R., Rabideau D., Rubio L., and McIntosh R.M. Circulating immune complexes and serum immunoglobulins in acute poststreptococcal glomerulonephritis. Clin Nephrol 13 (1980) 1-4
13. Fish A.J., Herdman R.C., Michael A.F., Pickering R.J., and Good R.A. Epidemic glomerulonephritis associated with type 49 streptococcal pyodema. II. Correlative study of light, immunofluorescent and electron microscopic findings. Am J Med 48 (1970) 28-39
14. Morel-Maroger L., Leathem A., and Richet G. Glomerular abnormalities in nonsystemic disease. Relationship between findings by light microscopy and immunofluorescence in 433 renal biopsy specimens. Am J Med 53 (1972) 170-184
15. Yoshizawa N., Suzuki Y., Oshima S., et al. Asymptomatic acute poststreptococcal glomerulonephritis following upper respiratory tract infections caused by Group A streptococci. Clin Nephrol 46 (1966) 296-301
16. West C.D., and McAdams A.J. Serum and glomerular IgG in poststreptococcal glomerulonephritis are correlated. Pediatr Nephrol 12 (1998) 392-396
17. Kikuchi M. Lymphadenitis showing focal reticulum cell hyperplasia with nuclear debris and phagocytosis. Nippon Ketsueki Gakkai Zasshi 35 (1972) 379-380
18. Fujimoto Y., Kozima Y., and Yamaguchi K. Cervical subacute necrotizing lymphadenitis. A new clinicopathologic agent. Naika 30 (1972) 920-927
19. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy 16 (1967) 178-222
20. Burns J.C., and Glode M.P. Kawasaki syndrome. Lancet 364 (2004) 533-544
21. Newburger J.W., Takahashi M., Gerber M.A., et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114 (2004) 1708-1733
22. Newburger J.W., Takahashi M., Beiser A.S., et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324 (1991) 1633-1639
23. Lee K.Y., Han J.W., Hong J.H., Lee H.S., Lee J.S., and Whang K.T. Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: laboratory Profiles according to duration of fever. J Korean Med Sci 19 (2004) 501-504
24. Cook L., Howard J.F., and Folds J.D. Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis. J Clin Immunol 8 (1988) 23-31
25. Koffman B.M., and Dalakas M.C. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations; Assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 20 (1997) 1102-1107
26. Dalakas M.C. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines. Muscle Nerve 22 (1999) 1479-1497
27. Clark W.F., Rock G.A., Buskard N., et al. The therapeutic plasma exchange: an update from the Canadian Apheresis Group. Ann Intern Med 131 (1999) 453-462
28. Sultan Y., Kazatchkine M.D., Maissoneuve P., and Nydegger U.E. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 2 (1984) 765-768
29. Evans M.J., Suenaga R., and Abdou N.I. Detection and purification of antiidiotypic antibody against anti-DNA in intravenous immune globulin. J Clin Immunol 11 (1991) 291-295
30. Lee K.Y., Koh D.K., Lee J.S., and Whang K.T. Varying effects of intravenous immunoglobulin on mononuclear cell proliferation in vitro. J Korean Med Sci 516 (2001) 544-548
31. Debre M., Bonnet M.C., Fridman W.H., et al. Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 342 (1993) 945-949
32. Wang T., Xu M., Ji L., and Yang R. Splenectomy for chronic idiopathic thrombocytopenic purpura in children: a single center study in China. Acta Haematol 115 (2006) 39-45
33. Berk J.E., Kizu H., Wilding P., and Searcy R.L. Macroamylasemia: a newly recognized cause for elevated serum amylase activity. N Engl J Med 277 (1967) 941-946
34. Posen S., Lee C., Vines R., Kilham H., Latham S., and Keefe J.F. Transient hyperphosphatasemia of infancy: an insufficiently recognized syndrome. Clin Chem 23 (1977) 292-294
35. Klonoff D.C. Macroamylasemia and other immunoglobulin-complexed enzyme disorders. West J Med 133 (1980) 392-407
36. Galasso P.J., Litin S.C., and O'brien J.F. The macroenzymes: a clinical review. Mayo Clin Proc 68 (1993) 349-354
37. Longworth L.G., and MacInnes D.A. An electrophoretic study of nephrotic sera and urine. J Exp Med 7 (1940) 77-82
38. Giangiacomo J., Creary G., Cole B.R., Hoffsten P., and Robson A.M. Serum immunoglobulins in the nephrotic syndrome: a possible cause of minimal-change nephrotic syndrome. N Engl J Med 293 (1975) 8-12
39. Song Y.H., Lee K.Y., Kim D.U., Koh D.K., and Lee B.C. The levels of IgG subclasses and vaccine-induced viral antibodies in childhood minimal changed nephrotic syndrome. J Korean Soc Pediatr Nephrol 9 (2005) 143-148
40. Gitlin D., Janeway C.A., and Farr L.E. Studies on the metabolism of plasma proteins in nephrotic syndrome. I. Albumin, gammaglobulin and iron-binding globulin. J Clin Invest 35 (1956) 44-55
41. Waldmann T.A., Strober W., and Mogielnicki P.P. The renal handling of lower molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome or uremia. J Clin Invest 51 (1972) 2162-2174
42. Beaman M., Oldfield S., Maclennan I.C.M., Michael J., and Adu D. Hypogammaglobulinemia in nephrotic rats is attributable to hypercatabolism of IgG. Clin Exp Immunol 74 (1984) 425-430
43. Al-Bander H.A., Martin V.I., and Kaysen G.A. Plasma IgG pool is not defended from urinary loss in nephrotic syndrome. Am J Physiol 262 (1992) F333-F337
44. Brocklebank T., Cooper E.H., and Richmond K. Sodium dodecyl sulphate polyacrylamide gel electrophoresis patterns of proteinuria in various renal diseases of childhood. Pediatr Nephrol 5 (1991) 371-375
45. Ramjee G., Coovadia H.M., and Adhikari M. Sodium dodecyl sulphate polyacrylamide gel electrophoresis of urinary proteins in steroid-responsive and steroid-resistant nephrotic syndrome in children. Pediatr Nephrol 8 (1994) 653-656
46. Ooi B.S., Ooi Y.M., Hsu A., and Hurtubise P.E. Diminished synthesis immunoglobulin by peripheral lymphocytes of patients with idiopathic membranous glomerulopathy. J Clin Invest 65 (1978) 789-797
47. Beale M.G., Nash G.S., Bertovich M.J., and MacDermott R.P. Immunoglobulin synthesis by peripheral blood mononuclear cells in minimal change nephrotic syndrome. Kidney Int 23 (1983) 380-386
48. Perheentupa J. Serum protein turnover in the congenital nephrotic syndrome. Experimental studies with 3H-tyrosine and 131-I-proteins. Ann Pediatr Fenn 12 (1966) 189-233
49. Lobo E.D., Hansen R.J., and Balthasar J.P. Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 93 (2004) 2645-2648
50. Clarlton B., Schindhelm K., Smeby L.C., and Farrell P.C. Analysis of immunoglobulin G kinetics in the non-steady state. J Lab Clin Med 105 (1985) 312-320
51. 125I-labeled human intravenous IgG preparation (C-425) in rats and rabbits. I. Blood clearance, excretion into urine and feces, and brain uptake. Eur J Drug Metab Phamacokinet 14 (1989) 35-42
52. Vanholder R., Burgelman M., De Smet R., Voogeleere P., and Ringoir S. Two-pool versus single-pool models in the determination of urea kinetic parameters. Blood Purif 14 (1996) 437-450
53. Keysen G.A. Plasma composition in the nephrotic syndrome. Am J Nephrol 13 (1993) 347-359
54. Heremans J.F., and Heremans M.T. Immunoelectrophoresis. Acta Med Scand Suppl 367 (1961) 27-59
55. Glode D.W., Greipp P.R., and McGinnis M.H. Spectrum of albumin auto-agglutinins. Transfusion 13 (1973) 1-5
56. Lindstrom P., and Wager O. IgG autoantibody to human serum albumin studied by the ELISA technique. Scand J Immunol 7 (1978) 419-425
57. Toubi E., and Etzioni A. Intravenous immunoglobulin in immunodeficiency states. Clin Rev Allergy Immunol 29 (2005) 167-172